Past News
Joint CIPAC/FAO/WHO Meeting on update information
Lupin’s moxifloxacin prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Joint UNICEF-UNFPA-WHO Meeting for Manufacturers and Suppliers - 08-10 March 2022
The World Health Organization (WHO), together with the United Nation’s Children Fund (UNICEF) and the United Nations Population Fund (UNFPA), will hold a three-day virtual meeting on 8-10 March 202
Consultant - In Vitro Diagnostics Assessment
Contractual Arrangement: External consultant
Contract Duration: 8 months
Job Posting: Nov 15, 2021, 7:46:07 PM
WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
Molnupiravir invited for COVID-19
Molnupiravir 200 mg capsules for oral administration invited for COVID-19.
WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
ACME Lab’s dispersible zinc tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
PT Sanbe’s levofloxacin tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Micro Labs’ paediatric ethambutol prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Nitrosamine concerns in rifampicin products - Update
A nitrosamine impurity, 1-methyl-4-nitrosopiperazine (MeNP), was identified in rifampicin products.
1st Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit published
A 1st Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit is being published by
DEMO’s dexamethasone solution for injection prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First generic flucytosine tablet prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
Casirivimab and imdevimab combination invited for COVID-19
Casirivimab and imdevimab combination invited for COVID-19.
Protionamide tablet from Lekhim Joint Stock Company in Ukraine prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Remington’s levofloxacin tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s paediatric isoniazid/rifampicin dispersible tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: